PRP4K and ovarian cancer: Furthermore, ovarian carcinoma cells isolated from the ascites of a relapsed ovarian cancer patient initially responsive to taxanes, exhibited markedly reduced PRP4K expression compared to the primary tumour and correlated with taxane resistant disease (Corkery et al., 2015b).